Abstract
Circulating angiogenic cells (CACs) are a heterogeneous cell population of bone marrow (BM) origin. These cells are most commonly derived from the peripheral blood, bone marrow, and cord blood, and are one of the leading candidates for promoting vascularization in tissue engineering therapies. CACs can be isolated by culturing peripheral blood mononuclear cells (PBMCs) on fibronectin or by flow cytometry to obtain more specific subpopulations. Here we will describe how to generate a population of CACs, and how to characterize the cells and confirm their phenotype. Also, we will provide select methods that can be used to assess the angiogenic and endothelial cell-like properties of the CACs.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Asahara T, Murohara T, Sullivan A et al (1997) Isolation of putative progenitor endothelial cells for angiogenesis. Science 275:964–967
Asahara T, Takahashi T, Masuda H et al (1999) VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J 18:3964–3972
Grenier G, Scime A, Le Grand F et al (2007) Resident endothelial precursors in muscle, adipose, and dermis contribute to postnatal vasculogenesis. Stem Cells 25:3101–3110
Tamaki T, Akatsuka A, Ando K et al (2002) Identification of myogenic-endothelial progenitor cells in the interstitial spaces of skeletal muscle. J Cell Biol 157:571–577
Asahara T, Kawamoto A, Masuda H (2011) Concise review: circulating endothelial progenitor cells for vascular medicine. Stem Cells 29:1650–1655
Moreno PR, Sanz J, Fuster V (2009) Promoting mechanisms of vascular health: circulating progenitor cells, angiogenesis, and reverse cholesterol transport. J Am Coll Cardiol 53:2315–2323
Fadini GP, Losordo D, Dimmeler S (2012) Critical reevaluation of endothelial progenitor cell phenotypes for therapeutic and diagnostic use. Circ Res 110:624–637
Gilbert PM, Blau HM (2011) Engineering a stem cell house into a home. Stem Cell Res Ther 2:3
Kuraitis D, Giordano C, Ruel M et al (2012) Exploiting extracellular matrix-stem cell interactions: a review of natural materials for therapeutic muscle regeneration. Biomaterials 33:428–443
Segers VF, Lee RT (2011) Biomaterials to enhance stem cell function in the heart. Circ Res 109:910–922
Nunes SS, Song H, Chiang CK et al (2011) Stem cell-based cardiac tissue engineering. J Cardiovasc Transl Res 4:592–602
Delewi R, Andriessen A, Tijssen JG et al (2013) Impact of intracoronary cell therapy on left ventricular function in the setting of acute myocardial infarction: a meta-analysis of randomised controlled clinical trials. Heart 99:225–232
Jeevanantham V, Butler M, Saad A et al (2012) Adult bone marrow cell therapy improves survival and induces long-term improvement in cardiac parameters: a systematic review and meta-analysis. Circulation 126:551–568
Amini AR, Laurencin CT, Nukavarapu SP (2012) Differential analysis of peripheral blood- and bone marrow-derived endothelial progenitor cells for enhanced vascularization in bone tissue engineering. J Orthop Res 30:1507–1515
Critser PJ, Voytik-Harbin SL, Yoder MC (2011) Isolating and defining cells to engineer human blood vessels. Cell Prolif 44(Suppl 1):15–21
Zhang Z, Ito WD, Hopfner U et al (2011) The role of single cell derived vascular resident endothelial progenitor cells in the enhancement of vascularization in scaffold-based skin regeneration. Biomaterials 32:4109–4117
Hirschi KK, Ingram DA, Yoder MC (2008) Assessing identity, phenotype, and fate of endothelial progenitor cells. Arterioscler Thromb Vasc Biol 28:1584–1595
Favre J, Terborg N, Horrevoets AJ (2013) The diverse identity of angiogenic monocytes. Eur J Clin Invest 43:100–107
Kalka C, Masuda H, Takahashi T et al (2000) Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci U S A 97:3422–3427
Kuraitis D, Hou C, Zhang Y et al (2011) Ex vivo generation of a highly potent population of circulating angiogenic cells using a collagen matrix. J Mol Cell Cardiol 51:187–197
Mackie AR, Losordo DW (2011) CD34-positive stem cells: in the treatment of heart and vascular disease in human beings. Tex Heart Inst J 38:474–485
Yang J, Ii M, Kamei N et al (2011) CD34+ cells represent highly functional endothelial progenitor cells in murine bone marrow. PLoS One 6:e20219
Garmy-Susini B, Varner JA (2005) Circulating endothelial progenitor cells. Br J Cancer 93:855–858
Peichev M, Naiyer AJ, Pereira D et al (2000) Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood 95:952–958
Sofrenovic T, McEwan K, Crowe S et al (2012) Circulating angiogenic cells can be derived from cryopreserved peripheral blood mononuclear cells. PLoS One 7:e48067
Werner N, Kosiol S, Schiegl T et al (2005) Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 353:999–1007
Khan SS, Solomon MA, McCoy JP Jr (2005) Detection of circulating endothelial cells and endothelial progenitor cells by flow cytometry. Cytometry B Clin Cytom 64:1–8
Shepherd RM, Capoccia BJ, Devine SM et al (2006) Angiogenic cells can be rapidly mobilized and efficiently harvested from the blood following treatment with AMD3100. Blood 108:3662–3667
Steinmetz M, Nickenig G, Werner N (2010) Endothelial-regenerating cells: an expanding universe. Hypertension 55:593–599
Yip HK, Chang LT, Chang WN et al (2008) Level and value of circulating endothelial progenitor cells in patients after acute ischemic stroke. Stroke 39:69–74
Rafii S, Lyden D (2003) Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nat Med 9:702–712
Werner N, Wassmann S, Ahlers P et al (2007) Endothelial progenitor cells correlate with endothelial function in patients with coronary artery disease. Basic Res Cardiol 102:565–571
Delorme B, Basire A, Gentile C et al (2005) Presence of endothelial progenitor cells, distinct from mature endothelial cells, within human CD146+ blood cells. Thromb Haemost 94:1270–1279
Acknowledgements
This work was supported by the Canadian Institutes of Health Research (to MR and EJS). BM was supported by a University of Ottawa Cardiology Research Endowment Fellowship.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this protocol
Cite this protocol
Ostojic, A., Crowe, S., McNeill, B., Ruel, M., Suuronen, E.J. (2014). Preparation and Characterization of Circulating Angiogenic Cells for Tissue Engineering Applications. In: Radisic, M., Black III, L. (eds) Cardiac Tissue Engineering. Methods in Molecular Biology, vol 1181. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-1047-2_3
Download citation
DOI: https://doi.org/10.1007/978-1-4939-1047-2_3
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-1046-5
Online ISBN: 978-1-4939-1047-2
eBook Packages: Springer Protocols